Raptim Research Pvt. Ltd

Welcome to Raptim Research Pvt. Ltd.! Raptim, a global independent and internationally accredited Clinical Research Organization (CRO), established in 2005, supporting the end-to-end services under the Clinical Research domain - Bioequivalence, IVRT/IVPT & BCS Biowaiver option; for all Pharmaceutical companies worldwide. Raptim stands for Rapid and it acts as a catalyst to hasten the regulatory submissions and approvals of customers products. We are market leader among independent Indian CROs, with the highest quality standards and quick turnaround times. We have a strong regulatory track record and numerous accreditation/approvals from global regulatory agencies like USFDA, WHO, ISP Chile, NABL, DCGI &...

Ba/be studies,clinical endpoint & pk end point patient studies,clinical trial,sensitive analytical method,special population be studies,ivrt/ivpt,transdermal – sensitization/irritation,inhalation,skin blanching assay,state of art clinical pharmacology units,first to file projects,caco2 permeability studies,complex studies,regulatory support,personal healthcare and dermatology,project management,personal healthcare and dermatology,vasoconstrictor studies,and scientific approach

Raptim research pvt. ltd operates in the Pharmaceutical manufacturing industry.

Raptim research pvt. ltd's revenue is 11m - 100m

Raptim research pvt. ltd has 501 - 1000 employees.